Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filedfiledCritical
Priority to ECSP993206priorityCriticalpatent/ECSP993206A/en
Publication of ECSP993206ApublicationCriticalpatent/ECSP993206A/en
Pharmaceuticals Containing Other Organic And Inorganic Compounds
(AREA)
Abstract
La presente invención se relaciona con nuevo método para mejorar la farmacocinética del tipranavir; que consiste en administrar una combianción de una cantidad terapéuticamente eficaz de tipranavir o una sal farmacéuticamente aceptable del mismo, y una cantidad terapéuticamente eficaz de ritonavir o una sal farmacéuticamente aceptable del mismo, a un humano que necesita de dicho tratamiento.The present invention relates to a new method to improve the pharmacokinetics of tipranavir; consisting of administering a combination of a therapeutically effective amount of tipranavir or a pharmaceutically acceptable salt thereof, and a therapeutically effective amount of ritonavir or a pharmaceutically acceptable salt thereof, to a human in need of such treatment.
ECSP9932061999-11-041999-11-04
METHOD TO IMPROVE THE PHARMACOKINETICS OF TIPRANAVIR
ECSP993206A
(en)
Non-aqueous pharmaceutical gel composition containing at least one vitamin d or one vitamin d analogue and at least one corticosteroid and its use in the manufacture of a medicament for treatment of psoriasis
Use of escitalopram or a pharmaceutically acceptable salt thereof to prepare a medicament useful in the treatment of post-traumatic stress disorder (divisional sol. 1799-00).